BrownellBHughesJT. The distribution of plaques in the cerebrum in multiple sclerosis. J Neurol Neurosurg Psychiatry1962; 25: 315–20.
2.
LumsdenCE. The neuropathology of multiple sclerosis. In: VinkenPJBruynGW (eds) Handbook of clinical neurology. Vol 9. Amsterdam: North-Holland, 1970, pp. 217–309.
3.
KiddDBarkhofFMcConnellR. Cortical lesions in multiple sclerosis. Brain1999; 122: 17–26.
4.
PetersonJWBöLMörkS. Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions. Ann Neurol2001; 50: 389–400.
5.
HowellOWReevesCANicholasR. Meningeal inflammation is widespread and linked to cortical pathology in multiple sclerosis. Brain2011; 134: 2755–71.
6.
ChoiSRHowellOWCarassitiD. Meningeal inflammation plays a role in the pathology of primary progressive multiple sclerosis. Brain2012; 135: 2925–37.
ChatawayJSchuererNAlsanousiA. Effect of high-dose simvastatin on brain atrophy and disability in secondary progressive multiple sclerosis (MS-STAT): a randomised, placebo-controlled, phase 2 trial. Lancet2014; 383(9936): 2213–21.
